Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q56241031)
Watch
English
ABL1 P-Loop Mutation
genetic variant
P-Loop Mutation
In more languages
default for all languages
No label defined
No description defined
edit
Statements
biological variant of
ABL1
1 reference
stated in
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/variants/2375
negative therapeutic predictor for
bosutinib
determination method or standard
CIViC evidence level B
rating
CIViC 3-star trust rating
medical condition treated
chronic myeloid leukemia
statement disputed by
Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
1 reference
curator
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/6336
stated in
Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
bosutinib
determination method or standard
CIViC evidence level B
rating
CIViC 2-star trust rating
medical condition treated
chronic myeloid leukemia
statement disputed by
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
1 reference
curator
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/6997
stated in
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
imatinib
determination method or standard
CIViC evidence level C
rating
CIViC 2-star trust rating
medical condition treated
chronic myeloid leukemia
1 reference
curator
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/evidence/8094
stated in
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis
Identifiers
CIViC variant ID
2375
1 reference
stated in
CIViC database
retrieved
23 May 2022
reference URL
https://civic.genome.wustl.edu/links/variants/2375
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit